Capravirine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Capravirine
Capravirine.png
Identifiers
CAS number 178979-85-6 YesY
PubChem 1783
ChemSpider 1717 N
ChEMBL CHEMBL435128 N
Jmol-3D images Image 1
Properties
Molecular formula C20H20Cl2N4O2S
Molar mass 451.37 g/mol
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
 N (verify) (what is: YesY/N?)
Infobox references

Capravirine was a non-nucleoside reverse transcriptase inhibitor which reached phase II trials before development was discontinued by Pfizer. Both phase IIb trials which were conducted failed to demonstrate that therapy with capravirine provided any significant advantage over existing triple-drug HIV therapies, and pharmacology studies showed that capravirine may interact with other HIV drugs.